All Stories

  1. Reoperations After Bariatric Surgery in 26 Years of Follow-up of the Swedish Obese Subjects Study

    Article • JAMA Surgery, January 2019, American Medical Association (AMA)

    Prof Stephan Hjorth

  2. Dose-Response-Time Data Analysis

    Article • Pharmacological Reviews, December 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Professor Johan Gabrielsson, Prof Stephan Hjorth, Assoc Professor Mats Jirstrand

  3. Lost in translation: What's in an EC? Innovative PK/PD reasoning in the drug development context

    Article • European Journal of Pharmacology, September 2018, Elsevier

    Prof Stephan Hjorth

  4. Integration of Pharmacokinetic and Pharmacodynamic Reasoning and Its Importance in Drug Discovery

    Article • August 2018, Wiley

    Prof Stephan Hjorth

  5. Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese subjects

    Article • International Journal of Obesity, May 2018, Springer Science + Business Media

    Prof Stephan Hjorth

  6. In vivo potency revisited – Keep the target in sight

    Article • Pharmacology & Therapeutics, April 2018, Elsevier

    Prof Stephan Hjorth

  7. Looking back (and in)to the future: A personal reflection on ‘Serotonin autoreceptor function and antidepressant drug action’ (Hjorth et al., 2000)

    Article • Journal of Psychopharmacology, July 2016, SAGE Publications

    Prof Stephan Hjorth

  8. Pattern Recognition in Pharmacodynamic Data Analysis

    Article • The AAPS Journal, November 2015, American Association of Pharmaceutical Scientists (AAPS)

    Prof Stephan Hjorth

  9. PK/PD Modeling of CNS Drug Candidates

    Article • January 2015, Wiley

    Prof Stephan Hjorth

  10. Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples

    Article • European Journal of Pharmaceutical Sciences, January 2015, Elsevier

    Prof Stephan Hjorth

  11. Modeling energy intake by adding homeostatic feedback and drug intervention

    Article • Journal of Pharmacokinetics and Pharmacodynamics, November 2014, Springer Science + Business Media

    Prof Stephan Hjorth

  12. Binding properties of antagonists to Cannabinoid receptors in intact cells

    Article • Fundamental and Clinical Pharmacology, March 2011, Wiley

    Prof Stephan Hjorth

  13. Dynamic and Kinetic Effects of Chronic Citalopram Treatment in Experimental Hepatic Encephalopathy

    Article • Clinical Neuropharmacology, November 2000, Wolters Kluwer Health

    Prof Stephan Hjorth

  14. Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor

    Article • Brain Research, July 1999, Elsevier

    Prof Stephan Hjorth

  15. Potassium-Evoked Neuronal Release of Serotonin in Experimental Chronic Portal-Systemic Encephalopathy

    Article • Metabolic Brain Disease, September 1997, Springer Science + Business Media

    Prof Stephan Hjorth

  16. p-Chloroamphetamine- and d-Fenfluramine-Induced Brain Serotonin Release in Experimental Portal-Systemic Encephalopathy

    Article • Metabolic Brain Disease, September 1997, Springer Science + Business Media

    Prof Stephan Hjorth

  17. (−)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

    Article • European Journal of Pharmacology, May 1996, Elsevier

    Prof Stephan Hjorth

  18. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain

    Article • Synapse, March 1995, Wiley

    Prof Stephan Hjorth

  19. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors

    Article • European Journal of Pharmacology, August 1994, Elsevier

    Prof Stephan Hjorth

  20. Differences in the In Vitro and In Vivo 5-Hydroxytryptamine Extraction Performance Among Three Common Microdialysis Membranes

    Article • Journal of Neurochemistry, November 1992, Wiley

    Prof Stephan Hjorth

  21. (−)-penbutolol as a blocker of central 5-HT1A receptor-mediated responses

    Article • European Journal of Pharmacology, November 1992, Elsevier

    Prof Stephan Hjorth

  22. ?2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, February 1992, Springer Science + Business Media

    Prof Stephan Hjorth

  23. Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor

    Article • Journal of Neuroscience Methods, September 1990, Elsevier

    Prof Stephan Hjorth

  24. Mixed agonist/antagonist properties of NAN-190 at 5-HT1A Receptors: Behavioural and in vivo brain microdialysis studies

    Article • Life Sciences, January 1990, Elsevier

    Prof Stephan Hjorth

  25. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation

    Article • European Journal of Pharmacology, August 1988, Elsevier

    Prof Stephan Hjorth

  26. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

    Article • European Journal of Pharmacology, September 1986, Elsevier

    Prof Stephan Hjorth

  27. Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (—)-3-PPP

    Article • European Journal of Pharmacology, January 1985, Elsevier

    Prof Stephan Hjorth